Ertapenem Drug Classification
Ertapenem is a carbapenem antibiotic, specifically a 1-β-methyl-carbapenem that is structurally related to beta-lactam antibiotics 1.
Chemical and Structural Classification
Ertapenem belongs to the carbapenem class, which is a subgroup of beta-lactam antibiotics. The FDA drug label explicitly describes it as "a sterile, synthetic, parenteral, 1-β methyl-carbapenem that is structurally related to beta-lactam antibiotics" 1. This classification is important because it defines both its mechanism of action and its antimicrobial spectrum.
Mechanism of Action
Like other beta-lactams, ertapenem inhibits bacterial cell wall synthesis by binding to and inhibiting penicillin-binding proteins 2. What distinguishes carbapenems from other beta-lactams is their enhanced resistance to beta-lactamases, including AmpC and extended-spectrum beta-lactamases (ESBLs), which makes them particularly valuable for treating multidrug-resistant infections 2, 3.
Unique Characteristics Within the Carbapenem Class
Ertapenem is classified as a Group 1 carbapenem 4, which distinguishes it from other carbapenems like imipenem, meropenem, and doripenem. The key differentiating feature is its narrower antimicrobial spectrum—it lacks reliable activity against Pseudomonas aeruginosa, Acinetobacter species, and enterococci 2, 3. This narrower spectrum, combined with its longer half-life of 4 hours allowing once-daily dosing, positions it specifically for community-acquired infections rather than late-onset nosocomial infections 3.
Clinical Context
Guidelines recognize ertapenem as a carbapenem option for treating moderate to severe infections, particularly intra-abdominal infections. The 2010 Surgical Infection Society and IDSA guidelines list it alongside other carbapenems (imipenem, meropenem, doripenem) but note its use specifically for "mild to moderately severe infection in adults" as single-agent empiric therapy 5. The 2022 ESCMID guidelines discuss ertapenem separately from imipenem/meropenem when comparing carbapenem options for third-generation cephalosporin-resistant Enterobacterales 6.
In summary: Ertapenem is a Group 1 carbapenem antibiotic within the broader beta-lactam class, distinguished by its narrower spectrum and once-daily dosing profile.